Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2Suspended 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Head & Neck 4Genitourinary 4Dermatologic 2Thoracic 1Other 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 594Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 485Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 267Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Interventions

imisopasem manganese 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hypotension × Genitourinary × Clear all
NCT07481851 2026-03-25

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Recruiting
102 enrolled
Genitourinary

Hypotension, Urologic Neoplasms

NCT04151264 2025-03-30

Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery

University of Giessen

Phase NA Completed
75 enrolled
GenitourinaryHead & Neck

Hypotension, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Acute Kidney Injury

NCT03882697 2020-12-21

Ability of Cardio Q for Prediction of Hypotension

Severance Hospital

Completed
125 enrolled
Genitourinary

Hypotension, Prostatic Neoplasms

NCT00033956 2005-06-24

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

MetaPhore Pharmaceuticals

Phase 1/2 Suspended
48 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Hypotension, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡